Market News

Alnylam Pharmaceuticals, Inc. (ALNY) Forms $124.86 Double Top; Profile of 1 Analysts Covering China Distance Education Holdings Limited (DL)

Among 3 analysts covering China Distance Education (NYSE:DL), 1 have Buy rating, 2 Sell and 0 Hold. Therefore 33% are positive. China Distance Education had 9 analyst reports since August 20, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Sunday, August 23 by Piper Jaffray. The stock of China Distance Education Holdings Limited (NYSE:DL) earned “Sell” rating by Zacks on Monday, September 7. The company was downgraded on Wednesday, August 26 by Zacks. As per Thursday, May 26, the company rating was downgraded by Credit Suisse. On Friday, September 2 the stock rating was upgraded by Credit Suisse to “Neutral”. As per Thursday, January 14, the company rating was reinitiated by Credit Suisse. The stock of China Distance Education Holdings Limited (NYSE:DL) earned “Underperform” rating by Credit Suisse on Friday, May 19. See China Distance Education Holdings Limited (NYSE:DL) latest ratings:

Alnylam Pharmaceuticals, Inc. (ALNY) formed double top with $133.60 target or 7.00% above today’s $124.86 share price. Alnylam Pharmaceuticals, Inc. (ALNY) has $12.38 billion valuation. The stock decreased 1.91% or $2.43 during the last trading session, reaching $124.86. About 1.47M shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since December 14, 2016 and is uptrending. It has outperformed by 16.84% the S&P500.

Investors sentiment increased to 0.83 in 2017 Q2. Its up 0.21, from 0.62 in 2017Q1. It improved, as 5 investors sold China Distance Education Holdings Limited shares while 8 reduced holdings. 0 funds opened positions while 8 raised stakes. 6.60 million shares or 2.18% more from 6.45 million shares in 2017Q1 were reported. Herald Inv Ltd holds 0.63% or 206,473 shares. Invesco Ltd has invested 0% in China Distance Education Holdings Limited (NYSE:DL). Cannell Peter B & owns 0.01% invested in China Distance Education Holdings Limited (NYSE:DL) for 23,279 shares. Moreover, State Street has 0% invested in China Distance Education Holdings Limited (NYSE:DL). Manufacturers Life Ins The invested in 4,000 shares. Guggenheim Capital Lc has invested 0% in China Distance Education Holdings Limited (NYSE:DL). The California-based Sensato Invsts Ltd Limited Liability Company has invested 0.82% in China Distance Education Holdings Limited (NYSE:DL). Barclays Pcl owns 0% invested in China Distance Education Holdings Limited (NYSE:DL) for 44 shares. Moreover, Jupiter Asset Limited has 0.31% invested in China Distance Education Holdings Limited (NYSE:DL). California Pub Employees Retirement owns 0% invested in China Distance Education Holdings Limited (NYSE:DL) for 39,200 shares. 6,390 were reported by Deutsche Natl Bank Ag. Bamco New York holds 0% or 38,229 shares. Fil Limited reported 0.04% of its portfolio in China Distance Education Holdings Limited (NYSE:DL). Moreover, Wells Fargo & Mn has 0% invested in China Distance Education Holdings Limited (NYSE:DL). 356,000 were accumulated by Renaissance Technology Ltd Company.

China Distance Education Holdings Limited provides online and offline education services, and sells related products in the PeopleÂ’s Republic of China. The company has market cap of $316.78 million. It operates through three divisions: Online Education Services, Business Start-Up Training Services, and The Sale of Learning Simulation Software. It has a 21.45 P/E ratio. The firm offers online professional education services in accounting, healthcare, and engineering and construction industries; and other professional education courses, such as the national judicial examination, online test-preparation courses for self-taught learners pursuing higher education diplomas or degrees, test preparation courses for university students, and online language courses.

The stock increased 0.21% or $0.02 during the last trading session, reaching $9.61. About 66,958 shares traded. China Distance Education Holdings Limited (NYSE:DL) has declined 28.21% since December 14, 2016 and is downtrending. It has underperformed by 44.91% the S&P500.

Since September 20, 2017, it had 0 insider purchases, and 2 insider sales for $18.35 million activity. $7.68M worth of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) was sold by Greene Barry E.

Investors sentiment decreased to 0.92 in Q2 2017. Its down 0.60, from 1.52 in 2017Q1. It dropped, as 24 investors sold Alnylam Pharmaceuticals, Inc. shares while 49 reduced holdings. 49 funds opened positions while 62 raised stakes. 85.40 million shares or 6.40% more from 80.26 million shares in 2017Q1 were reported. Utah Retirement Systems has invested 0.03% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Tiaa Cref Invest Mgmt Ltd owns 508,852 shares for 0.03% of their portfolio. Quantbot Techs L P holds 0.02% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 3,139 shares. Great Point Ptnrs Limited Company has invested 3.96% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). 3.43M are held by Baillie Gifford &. Tocqueville Asset Management Lp accumulated 16,575 shares. Bradley Foster & Sargent Incorporated Ct holds 4,115 shares. New York State Common Retirement Fund reported 202,988 shares. Art Advsrs Lc invested in 50,500 shares. Clearbridge Invests Ltd Liability Co has invested 0% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Financial Architects holds 140 shares. Commonwealth Equity Svcs holds 7,299 shares. Ellington Mgmt Gp Ltd accumulated 5,900 shares. Moreover, Nationwide Fund Advsrs has 0% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 11,197 shares. Evercore Wealth Mgmt, New York-based fund reported 600 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *